Synklino
0 followers
‌
Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.
Industries
Headquarters
Employees
Links
Org chart
Thomas Kledal
CEO & Co-Founder
Thomas Kledal
Collapse
Mads Jeppesen
CMC Project Director & Co-Founder
Josi Holz
Senior Strategic Advisor
Mads Gravers Jeppesen
Head of Discovery
Mette M Rosenkilde
Member of the Board of Directors & Co-Founder
Søren Neve
Head of Pharmacology
